|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 9/12 | (2006.01) |
| A61K 9/14 | (2006.01) | ||
| C08B 37/16 | (2006.01) |
| (11) | Number of the document | 2708225 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13184888.9 |
| Date of filing the European patent application | 2005-04-22 | |
| (97) | Date of publication of the European application | 2014-03-19 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-26 |
| (46) | Date of publication of the claims translation | 2019-04-10 |
| (30) | Number | Date | Country code |
| 564892 P | 2004-04-23 | US |
| (72) |
Pipkin, James D, US
Mosher, Gerold L., US
Hecker, Douglas B, US
|
| (73) |
CyDex Pharmaceuticals, Inc.,
3911 Sorrento Valley Boulevard Suite 110, San Diego, CA 92121,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | DPI kompozicija, turinti sulfoalkilo eterio ciklodekstrino |
| DPI Formulation Containing Sulfoalkyl Ether Cyclodextrin |
| Payment date | Validity (years) | Amount | |
| 2024-04-03 | 347.00 EUR |